These findings indicate that the anti-obesity and glucose-lowering effects of VS may be due to the inhibition of HFD-induced adipocyte hypertrophy by suppressing adipocyte differentiation, accompanied by enhanced insulin sensitivity. Here, INS is linked to obesity disorder.